Work

FRI0429 NON TOPICAL PHARMACOLOGICAL TREATMENT OF EARLY, UNTREATED (DMARD-NAïVE, SYSTEMIC THERAPY-NäIVE) PSORIATIC DISEASE: A SYSTEMATIC REVIEW

Year: 2019

Type: review

Study design: Systematic Review

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2019-eular.1837

Authors: Gabriele De Marco, Anna Berekméri, Laura C. Coates, Sayam Dubash, Dafna D. Gladman, Ennio Lubrano, Dennis Mcgonagle, Farrouq Mahmood, Antonio Marchesoni, Alexis Ogdie, Miriam Wittmann, Helena Marzo-Ortega, Philip Helliwell

Institutions: University of Leeds, University of Oxford, University of Toronto, Toronto Western Hospital, Krembil Research Institute, University of Molise, Istituto Ortopedico Gaetano Pini, University of Pennsylvania

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Gilead Sciences, Celgene, Prothena

OpenAlex ID: W2950668732

FWCI:

Cites:

Cited by:

Related to: 10